About Prodigy Health
Prodigy Health is a company based in Austin (United States) founded in 2001, and was acquired by Morris and Dickson in January 2026. Specialty pharmaceuticals are distributed nationally with consignment and delivery services. Prodigy Health has raised $110 million across 2 funding rounds from investors including Aetna, One Equity Partners and Gibraltar Business Capital. Its chief executive, as recorded, is Jon Houssian. Prodigy Health offers products and services including Specialty Pharmaceuticals and Consignment Services.
Company details
Prodigy Health was founded in 2001 and is headquartered in Austin, United States. Operations focus on national distribution of specialty pharmaceuticals, including IVIG and albumin. Services encompass on-demand consignment, same-day delivery, and 503B outsourcing for compounded sterile preparations via an FDA-registered partner. A customer portal is provided for inventory visibility and order tracking, alongside a direct-to-manufacturer generic drug program. Accreditations from industry bodies are maintained.
- Headquarters Austin, United States
- Stage Acquired
- Website prodigyhealth.com
- Acquired by Aetna (Jun 2011)
- Legal Name Prodigy Health
- Total Equity Funding$110M (USD)
in 2 rounds
- Latest Funding Round$30M (USD), Debt – Conventional
Jan 2025
- InvestorsAetna
& 3 more
- Acquired by
Products & Services of Prodigy Health
Prodigy Health offers a comprehensive portfolio of products and services, including Specialty Pharmaceuticals and Consignment Services.
Specialty pharmaceuticals are distributed to hospitals, infusion centers, and pharmacies to meet healthcare needs.
High-price drugs are provided on a consignment basis to eliminate inventory expiry and shipping costs for facilities.
Funding Insights of Prodigy Health
Prodigy Health has successfully raised a total of $110M across 2 strategic funding rounds. The most recent funding activity was a Debt β Conventional round of $30 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $110M
- Total Rounds 2
- Last Round Debt – Conventional β $30M
- First Round $110M
(Jun 2008)
- Investors Count 2
All 2 funding rounds of Prodigy Health with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2025 | $30M | Debt – Conventional | β | β | |
| Jun 2008 | $110M | Private Equity Round | β | β |
4 investors in total: 4 institutional.
Investors in Prodigy Health
Prodigy Health has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Aetna, One Equity Partners and Gibraltar Business Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are made in North America and Europe. | 2001 | oneequity.com | New York, United States | |
Working capital and asset-based loans are provided to businesses. | 2009 | gibraltarbc.com | Northbrook, United States | |
Health insurance plans are provided by Aetna for diverse needs. | 1853 | aetna.com | Hartford, United States | |
Distributes pharmaceuticals and healthcare products to health systems, pharmacies, and alternate care facilities. | 1841 | morrisdickson.com | Shreveport, United States |
Investor details for Prodigy Health
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Prodigy Health
1 people are tracked at Prodigy Health (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jon Houssian | CEO & President | Leadership |
Complete people profiles for Prodigy Health
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Prodigy Health
5 dated milestones of Prodigy Health across 25 years, from founding to its latest funding, stage changes and deals.
- Founded Prodigy Health is founded.
- Funding First funding round of $110.0M.
- Exit Acquired by Aetna.
- Funding Latest funding round, Debt β Conventional, of $30.0M.
- Exit Acquired by Morris and Dickson.
Web traffic of Prodigy Health
The website of Prodigy Health (prodigyhealth.com) receives about 1.4K visits a month.
- Monthly visits1.4K
▼ 36.9% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Prodigy Health
Prodigy Health was founded in 2001 and raised its 1st funding round 7 years after it was founded.
Prodigy Health is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Jon Houssian is the CEO of Prodigy Health, as recorded in our data.
Prodigy Health is a funded company, having raised a total of $110M across 2 funding rounds to date. The company's 1st funding round was a Private Equity Round of $110M, raised on Jun 2008.
Prodigy Health was founded in 2001 and is headquartered in Austin, United States. Operations focus on national distribution of specialty pharmaceuticals, including IVIG and albumin. Services encompass on-demand consignment, same-day delivery, and 503B outsourcing for compounded sterile preparations via an FDA-registered partner. A customer portal is provided for inventory visibility and order tracking, alongside a direct-to-manufacturer generic drug program. Accreditations from industry bodies are maintained.
Prodigy Health offers Specialty Pharmaceuticals and Consignment Services.
Prodigy Health has 4 investors. Key investors include Aetna, One Equity Partners, Gibraltar Business Capital, and Morris and Dickson.
Prodigy Health operates through Prodigy Health.
Yes. Prodigy Health was acquired by Aetna in June 2011.
